Korean-American singer Woosung of South Korean band The Rose has announced his upcoming 2024 ‘B4 We Die’ world tour, featuring concerts in Asia, Europe, the US and more.
Today (September 5), The Rose frontman Woosung took to his social media accounts to announce his upcoming 2024 ‘B4 We Die’ world tour with the release of its the official poster. The tour will kick off this October in Asia, with shows in Bangkok and Macau.
In the same month, the singer will also bring his tour to Oceania, with two performances in Australia and one in New Zealand. At the end of October, Woosung will head on the Europe leg of his 2024 tour, with concerts in the UK, followed by a France date in early-November.
Thereafter, the singer will head to the Americas for a four-date leg, featuring three in the US and one in Mexico. Ticketing and venue details for Woosung’s 2024 ‘B4 We Die’ world tour have yet to be announced. Keep tabs on this page for the latest updates.
The dates for Woosung’s 2024 ‘B4 We Die’ world tour are:
OCTOBER 2024
17: Bangkok, Thailand
19: Macau, China
23: Newtown, New South Wales, Australia
24: Melbourne, Victoria, Australia
27: Auckland, New Zealand
30: London, United Kingdom
NOVEMBER 2024
02: Paris, France
06: Brooklyn, New York
08: San Antonio, Texas
10: Mexico City, Mexico
17: Los Angeles, California
Woosung’s tour announcement comes a week after he dropped his new single ‘Day That I Died’. The song is part of the singer’s upcoming record ‘4444’, due out on October 4. The record is now available to pre-save and pre-order on his official website.
In other K-pop news, boy band ENHYPEN recently announced the first dates for their 2024 to 2025 ‘Walk The Line’ world tour, which will kick off in Seoul this October, followed by several shows in Japan.
Elsewhere, NCT rapper Taeyong, best known for leading its NCT 127 sub-unit, has announced the upcoming premiere of his first-ever solo concert film Taeyong: TY Track in Cinemas next month.
The post The Rose’s Woosung announces 2024 ‘B4 We Die’ world tour appeared first on NME.
